Resultats de la cerca - Peter Buontempo

  • Mostrar 1 - 2 resultats de 2
Refinar resultats
  1. 1
    Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120

    Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120 per Robert A. Ogert, Lisa Wojcik, Catherine Buontempo, Lei Ba, Peter Buontempo, Robert Ralston, Julie Strizki, John A. Howe

    Publicat 2008
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of the three poliovirus serotypes

    Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of the three poliovirus serotypes per Karen N Lentz, Allen Smith, Sheila C. Geisler, Stuart Cox, Peter Buontempo, Angela Skelton, Jason DeMartino, Edward J. Rozhon, Jerome Schwartz, Viyyoor Girijavallabhan, John F. O’Connell, Eddy Arnold

    Publicat 1997
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: